Life Science Compliance Update

June

2018

Finding The Golden Nuggets – OIG-HCCA Recommendations For Smaller Life Science Companies

Written by , Posted in Uncategorized

Carla-Marie Ulerie, Eric Davis, and Jon Wilkenfeld

Recently the OIG and the HCCA published a resource guide with recommendations for determining if a compliance program is effective. Since small to mid-sized pharma and medical device companies typically operate with limited compliance staff and financial resources, we identified recommendations that were relatively easy or low cost to implement but were rarely adopted. Based on our review we have determined the “golden nuggets” from that guide.


   or   

Topic tags:

Menu Title